Hsiu Yueh Lin
Investor Relations Contact bij CENTER LABORATORIES, INC.
Profiel
Hsiu Yueh Lin is currently a Director at Univision Pharmaceutical Co., Ltd., Head-Management at Center Laboratories, Inc. (since 1998), and a Member-Supervisory Board at Anhui Jinlac.
Biotech Ltd.
She was previously a Director at TPG Biologics, Inc. and a Member-Supervisory Board at glac Biotech Co., Ltd.
Ms. Lin received an undergraduate degree from National Cheng Kung University.
Actieve functies van Hsiu Yueh Lin
Bedrijven | Functie | Begin |
---|---|---|
CENTER LABORATORIES, INC. | Investor Relations Contact | - |
Univision Pharmaceutical Co., Ltd. | Director/Board Member | - |
Anhui Jinlac Biotech Ltd. | Director/Board Member | - |
Eerdere bekende functies van Hsiu Yueh Lin
Bedrijven | Functie | Einde |
---|---|---|
TPG BIOLOGICS INC | Director/Board Member | - |
GLAC BIOTECH CO., LTD. | Director/Board Member | - |
Opleiding van Hsiu Yueh Lin
National Cheng Kung University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
CENTER LABORATORIES, INC. | Health Technology |
Bedrijven in privébezit | 4 |
---|---|
Univision Pharmaceutical Co., Ltd. | |
glac Biotech Co., Ltd.
glac Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology glac Biotech Co., Ltd. engages in the production, research, development, and sales of probiotics. It offers probiotics in the application of healthcare, food, and agriculture. The company's products include functional probiotic powders and fermented products such as yogurt and yogurt ice cream. glac Biotech was founded on July 30, 2008 and is headquartered in Tainan, Taiwan. | Health Technology |
TPG Biologics, Inc.
TPG Biologics, Inc. Pharmaceuticals: MajorHealth Technology TPG Biologics, Inc. engages in the development of biopharmaceutical products. It offers antibody and protein drug design, cell line generation, process development, monoclonal antibody cell line similar drug products, and biological production for feasibility tests and animal studies. The company was founded on December 31, 2003 and headquartered in Taipei, Taiwan. | Health Technology |
Anhui Jinlac Biotech Ltd. |